Ching‐Hon Pui

92.0k total citations · 18 hit papers
629 papers, 45.5k citations indexed

About

Ching‐Hon Pui is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Ching‐Hon Pui has authored 629 papers receiving a total of 45.5k indexed citations (citations by other indexed papers that have themselves been cited), including 439 papers in Public Health, Environmental and Occupational Health, 290 papers in Pediatrics, Perinatology and Child Health and 248 papers in Hematology. Recurrent topics in Ching‐Hon Pui's work include Acute Lymphoblastic Leukemia research (435 papers), Childhood Cancer Survivors' Quality of Life (258 papers) and Acute Myeloid Leukemia Research (165 papers). Ching‐Hon Pui is often cited by papers focused on Acute Lymphoblastic Leukemia research (435 papers), Childhood Cancer Survivors' Quality of Life (258 papers) and Acute Myeloid Leukemia Research (165 papers). Ching‐Hon Pui collaborates with scholars based in United States, Germany and Singapore. Ching‐Hon Pui's co-authors include William E. Evans, Mary V. Relling, Raul C. Ribeiro, James R. Downing, Scott C. Howard, Jeffrey E. Rubnitz, John T. Sandlund, Dario Campana, Gaston K. Rivera and Susana C. Raimondi and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Ching‐Hon Pui

616 papers receiving 44.5k citations

Hit Papers

Treatment of Acute Lymphoblastic Leukemia 1991 2026 2002 2014 2006 2007 2008 2004 2002 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Acute Lymphoblastic Leukemia
    2006 1.4k citations Ching‐Hon Pui, William E. Evans profile →
  2. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
    2007 1.2k citations Charles G. Mullighan, Elaine Coustan‐Smith et al. profile →
  3. Acute lymphoblastic leukaemia
    2008 1.1k citations Ching‐Hon Pui, Leslie L. Robison et al. The Lancet profile →
  4. Acute Lymphoblastic Leukemia
    2004 850 citations Ching‐Hon Pui, Mary V. Relling et al. profile →
  5. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
    2002 819 citations Mignon L. Loh, Susana C. Raimondi et al. profile →
  6. BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
    2008 711 citations Charles G. Mullighan, Ching‐Hon Pui et al. profile →
  7. Acute Lymphoblastic Leukemia
    1998 639 citations Ching‐Hon Pui, William E. Evans profile →
  8. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
    2009 616 citations Elaine Coustan‐Smith, Charles G. Mullighan et al. profile →
  9. Preventing and Managing Toxicities of High-Dose Methotrexate
    2016 610 citations Scott C. Howard, Ching‐Hon Pui et al. profile →
  10. Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
    2011 592 citations Ching‐Hon Pui et al. Journal of Clinical Oncology profile →
  11. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
    2015 592 citations Ching‐Hon Pui, Jun J. Yang et al. Journal of Clinical Oncology profile →
  12. The Tumor Lysis Syndrome
    2011 583 citations Scott C. Howard, Ching‐Hon Pui et al. profile →
  13. Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
    1991 523 citations Ching‐Hon Pui, Raul C. Ribeiro et al. profile →
  14. Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus
    1999 495 citations Mary V. Relling, M L Hancock et al. profile →
  15. CREBBP mutations in relapsed acute lymphoblastic leukaemia
    2011 433 citations Charles G. Mullighan, Jinghui Zhang et al. profile →
  16. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
    2012 374 citations Ching‐Hon Pui, Charles G. Mullighan et al. Blood profile →
  17. Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia
    2015 306 citations Jun J. Yang, Wenjian Yang et al. Journal of Clinical Oncology profile →
  18. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
    2015 280 citations Sima Jeha, Ching‐Hon Pui et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Hon Pui United States 110 26.0k 16.8k 16.7k 10.5k 8.6k 629 45.5k
William E. Evans United States 93 15.6k 0.6× 7.4k 0.4× 11.3k 0.7× 9.4k 0.9× 6.7k 0.8× 386 34.0k
Mary V. Relling United States 97 14.5k 0.6× 6.5k 0.4× 12.3k 0.7× 8.6k 0.8× 7.6k 0.9× 381 33.5k
Rob Pieters Netherlands 79 11.4k 0.4× 7.9k 0.5× 6.3k 0.4× 9.3k 0.9× 4.2k 0.5× 518 22.9k
Raul C. Ribeiro United States 77 8.9k 0.3× 7.0k 0.4× 6.0k 0.4× 4.5k 0.4× 4.3k 0.5× 431 19.7k
Stephen E. Sallan United States 81 7.3k 0.3× 5.0k 0.3× 6.4k 0.4× 6.3k 0.6× 4.0k 0.5× 282 21.5k
Ravi Bhatia United States 85 4.5k 0.2× 8.9k 0.5× 4.4k 0.3× 4.8k 0.5× 5.9k 0.7× 463 21.8k
Gregory H. Reaman United States 68 6.3k 0.2× 3.1k 0.2× 4.9k 0.3× 4.2k 0.4× 3.6k 0.4× 306 15.8k
Stephanie J. Lee United States 85 6.8k 0.3× 15.8k 0.9× 4.0k 0.2× 2.9k 0.3× 5.7k 0.7× 629 26.1k
Elihu H. Estey United States 100 8.7k 0.3× 27.6k 1.6× 957 0.1× 16.0k 1.5× 8.6k 1.0× 687 39.7k
Emil J. Freireich United States 81 5.0k 0.2× 10.9k 0.7× 1.3k 0.1× 6.0k 0.6× 7.3k 0.8× 497 25.6k

Countries citing papers authored by Ching‐Hon Pui

Since Specialization
Citations

This map shows the geographic impact of Ching‐Hon Pui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hon Pui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hon Pui more than expected).

Fields of papers citing papers by Ching‐Hon Pui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Hon Pui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hon Pui. The network helps show where Ching‐Hon Pui may publish in the future.

Co-authorship network of co-authors of Ching‐Hon Pui

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Hon Pui. A scholar is included among the top collaborators of Ching‐Hon Pui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Hon Pui. Ching‐Hon Pui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Howard, Scott C., et al.. (2024). Publisher Correction: Tumour lysis syndrome. Nature Reviews Disease Primers. 10(1). 65–65. 1 indexed citations
2.
Hu, Zhongbo, et al.. (2024). Clinical Risk Factors for High‐Dose Methotrexate‐Induced Oral Mucositis Following Individualized Dosing. Cancer Medicine. 13(21). e70351–e70351. 2 indexed citations
3.
Jacola, Lisa M., Kevin R. Krull, Ching‐Hon Pui, et al.. (2016). Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol. Journal of Clinical Oncology. 34(11). 1239–1247. 116 indexed citations
4.
Pauley, Jennifer L., John C. Panetta, Deqing Pei, et al.. (2016). Prophylactic Trimethoprim-Sulfamethoxazole Does Not Affect Pharmacokinetics or Pharmacodynamics of Methotrexate. Journal of Pediatric Hematology/Oncology. 38(6). 449–452. 15 indexed citations
5.
Bhojwani, Deepa, Noah D. Sabin, Deqing Pei, et al.. (2014). Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 32(9). 949–959. 242 indexed citations
6.
Roberts, Kathryn G., Deqing Pei, Dario Campana, et al.. (2014). Outcomes of Children With BCR-ABL1 –Like Acute Lymphoblastic Leukemia Treated With Risk-Directed Therapy Based on the Levels of Minimal Residual Disease. Journal of Clinical Oncology. 32(27). 3012–3020. 165 indexed citations
7.
Krull, Kevin R., Tara M. Brinkman, Chenghong Li, et al.. (2013). Neurocognitive Outcomes Decades After Treatment for Childhood Acute Lymphoblastic Leukemia: A Report From the St Jude Lifetime Cohort Study. Journal of Clinical Oncology. 31(35). 4407–4415. 243 indexed citations
8.
Krull, Kevin R., Deepa Bhojwani, Heather M. Conklin, et al.. (2013). Genetic Mediators of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 31(17). 2182–2188. 77 indexed citations
9.
Krull, Kevin R., Nan Zhang, Aimee Santucci, et al.. (2013). Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation. Blood. 122(4). 550–553. 37 indexed citations
10.
Inaba, Hiroto, Elaine Coustan‐Smith, Xueyuan Cao, et al.. (2012). Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(29). 3625–3632. 136 indexed citations
11.
Ramsey, Laura B., John C. Panetta, Colton Smith, et al.. (2012). Genome-wide study of methotrexate clearance replicates SLCO1B1. Blood. 121(6). 898–904. 157 indexed citations
12.
Ciarimboli, Giuliano, Cynthia S. Lancaster, Eberhard Schlatter, et al.. (2012). Proximal Tubular Secretion of Creatinine by Organic Cation Transporter OCT2 in Cancer Patients. Clinical Cancer Research. 18(4). 1101–1108. 125 indexed citations
13.
Leung, Wing, Ching‐Hon Pui, Elaine Coustan‐Smith, et al.. (2012). Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood. 120(2). 468–472. 132 indexed citations
14.
Stow, Patricia, Laura Key, Xiaohua Chen, et al.. (2010). Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia. Blood. 115(23). 4657–4663. 103 indexed citations
15.
Kawedia, Jitesh D., Sue C. Kaste, Deqing Pei, et al.. (2010). Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 117(8). 2340–2347. 186 indexed citations
16.
Rubnitz, Jeffrey E., David Wichlan, Meenakshi Devidas, et al.. (2008). Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. Journal of Clinical Oncology. 26(13). 2186–2191. 53 indexed citations
17.
Yang, Lei, John C. Panetta, Xiangjun Cai, et al.. (2008). Asparaginase May Influence Dexamethasone Pharmacokinetics in Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 26(12). 1932–1939. 107 indexed citations
18.
Hijiya, Nobuko, John C. Panetta, Yinmei Zhou, et al.. (2006). Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood. 108(13). 3997–4002. 85 indexed citations
19.
Coustan‐Smith, Elaine, Raul C. Ribeiro, Patricia Stow, et al.. (2006). A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood. 108(1). 97–102. 91 indexed citations
20.
Thompson, Elizabeth, Judith A. Wilimas, Laura C. Bowman, et al.. (1990). Myeloid neoplasia in children treated for solid tumours. The Lancet. 336(8712). 417–421. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William E. Evans Breakdown of academic impact, for papers by Mary V. Relling Breakdown of academic impact, for papers by Rob Pieters Breakdown of academic impact, for papers by Raul C. Ribeiro Breakdown of academic impact, for papers by Stephen E. Sallan Breakdown of academic impact, for papers by Ravi Bhatia Breakdown of academic impact, for papers by Gregory H. Reaman Breakdown of academic impact, for papers by Stephanie J. Lee Breakdown of academic impact, for papers by Elihu H. Estey Breakdown of academic impact, for papers by Emil J. Freireich
Rankless by CCL
2026